Home > Insider Trading > Filing (0001354488-17-000512)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1489798	Janet Dillione	C/O Cormedix Inc. 1430 U.s. Highway 206, Suite 200 Bedminster NJ 07921		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-15	21,231	$0.48	39,969	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Phantom Stock	Acquisiton	2017-05-15	15,306	$0.00	15,306	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,306			No	4	A	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy Common Stock)	$2.24	2027-02-21	40,000	40,000	Direct
Common Stock	Restricted Stock Units	$0.00		15,357	15,357	Direct
Common Stock	Phantom Stock	$0.00		3,472	3,472	Direct
Common Stock	Phantom Stock	$0.00		4,143	4,143	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$3.03	2025-08-11	50,000	50,000	Direct
Common Stock	Phantom Stock	$0.00		1,415	1,415	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$1.91	2026-02-21	95,000	95,000	Direct
Common Stock	Phantom Stock	$0.00		3,831	3,831	Direct
Common Stock	Phantom Stock	$0.00		2,767	2,767	Direct
Common Stock	Phantom Stock	$0.00		4,335	4,335	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-02-21	40,000	40,000	Direct
	15,357	15,357	Direct
	3,472	3,472	Direct
	4,143	4,143	Direct
2025-08-11	50,000	50,000	Direct
	1,415	1,415	Direct
2026-02-21	95,000	95,000	Direct
	3,831	3,831	Direct
	2,767	2,767	Direct
	4,335	4,335	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $0.473 to $0.475. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.